Newsletter

Korea Disease Control and Prevention Agency Outlines Future Health Preparedness and Vaccine Development

Commissioner Ji Discusses Plans to Address Future Health Risks

Press Conference in Cheongju Highlights Health Preparations

At a press conference held in Cheongju, North Chungcheong Province, Commissioner Ji Young-mi of the Korea Disease Control and Prevention Agency outlined plans to address future health risks, including new infectious diseases and chronic illnesses.

Commissioner Ji emphasized the need to prepare for future infectious diseases and strengthen vaccine development capabilities to respond to 1 million patients per day within 100 to 200 days.

Last May, the Korea Disease Control and Prevention Agency announced a medium- to long-term plan to prepare for new infectious diseases, which has been fully implemented after approval at a meeting of relevant ministers.

In addition to preparing for future infectious diseases, Commissioner Ji highlighted the importance of addressing other neglected infectious diseases and eradicating chronic illnesses such as tuberculosis and malaria.

Furthermore, the Agency plans to strengthen prevention and control measures for both infectious and non-infectious diseases, utilizing community health surveys and national health and nutrition surveys to inform chronic disease management policies.

Additionally, the Agency will expand national vaccinations against influenza and HPV (human papillomavirus) and enhance international cooperation in preparing for infectious disease disasters.

Regarding the recent mycoplasma pneumonia epidemic, Commissioner Ji confirmed that the situation is not as dangerous as initially reported and emphasized the accessibility of antibiotic treatments.

Looking ahead, Commissioner Ji mentioned the potential adjustment of the Corona emergency level, with considerations for a change early next year in response to the winter respiratory infectious disease situation.

Lastly, Commissioner Ji emphasized the promotion of the Novavax vaccine to counter the XBB.1.5 mutant virus and increase vaccination rates to address future health risks.

Press conference in Cheongju… “Responding to 1 million patients per day and strengthening vaccine development capabilities within 100 to 200 days.”
Ji Young-mi, “Mycoplasma pneumonia is not a dangerous situation… antibiotic treatment is possible.” Ji Young-mi, director of the Korea Disease Control and Prevention Agency, said on the 12th, “Even if COVID-19 goes away, there is a lot of work to be done.

“We will be preparing for a variety of health risks, including new infectious diseases that occur regularly and chronic diseases,” he said.

Commissioner Ji said this at a press conference held in Cheongju, North Chungcheong Province on this day and emphasized, “In preparing for future infectious diseases that will come after Corona, we will be able to respond to 1 million patients a day and we have the ability. developing vaccines and treatments within 100 to 200 days.” .

Last May, the Korea Disease Control and Prevention Agency announced a medium- to long-term plan to prepare for new infectious diseases.

The content was approved at a meeting of relevant ministers last week and fully implemented.

Commissioner Ji added, “We will also pay attention to other infectious diseases that were relatively neglected during the three-year coronavirus pandemic,” and added, “There is a lot of work to be done to eradicate tuberculosis and malaria.”

He said it would strengthen the prevention and control of not only infectious diseases but also non-infectious diseases.

To this end, Commissioner Ji explained, “We will use the results of the community health survey and the national health and nutrition survey that are currently being conducted and link them to chronic disease management policies.”

In addition, he said he would expand national vaccinations against influenza and HPV (human papillomavirus) and strengthen cooperation with foreign countries in preparing for international infectious disease disasters.

Regarding the recent mycoplasma pneumonia epidemic, he said, “After contacting the Chinese health authorities, it is known to be exaggerated, and it is not a very dangerous situation as it is only half of the level in 2019.”

However, he suggested, “Since this is a disease that can be treated with antibiotics, we will examine the field medical system, including pediatrics, through a joint task force meeting.”

Regarding the adjustment of the Corona emergency level, Commissioner Ji said, “We will consider adjusting the level around early next year after passing the epidemic situation of the current winter respiratory infectious disease,” and added, “Even if it’ r level is adjusted, it will not become completely normal, and we will respond through the Central Quarantine Countermeasures Headquarters (Bangdae Headquarters).” “It is,” he explained.

In addition, he emphasized that he would promote the newly imported American Novavax vaccine to respond to the XBB.1.5 mutant virus and increase the vaccination rate.

/happy news

#Korea #Disease #Control #Prevention #Agency #Director #coronavirus #preparations #infectious #diseases